International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2422 - 2422
Published: March 7, 2025
The
double-stranded
RNA
editing
enzyme
ADAR1
connects
two
forms
of
genetic
programming,
one
based
on
codons
and
the
other
flipons.
recodes
in
pre-mRNA
by
deaminating
adenosine
to
form
inosine,
which
is
translated
as
guanosine.
also
plays
essential
roles
immune
defense
against
viruses
cancers
recognizing
left-handed
Z-DNA
Z-RNA
(collectively
called
ZNA).
Here,
we
review
various
aspects
biology,
starting
with
progressing
has
major
isoforms,
p110
protein
lacking
p150
Zα
domain
that
binds
ZNAs
high
affinity.
isoform
induced
interferon
targets
ALU
inverted
repeats,
a
class
endogenous
retroelement
promotes
their
transcription
retrotransposition
incorporating
Z-flipons
encode
G-flipons
G-quadruplexes
(GQ).
Both
include
Zβ
related
but
does
not
bind
ZNAs.
Here
report
strong
evidence
GQ
are
formed
co-transcriptionally
repeats
within
R-loops.
By
binding
GQ,
suppresses
ALU-mediated
alternative
splicing,
generates
most
reported
nonsynonymous
edits
R-loop
resolution.
recognition
nucleic
acid
conformations
programming
flipons
encoding
information
codons.
findings
suggest
into
editmers
might
improve
therapeutic
efficacy
ADAR1.
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(9)
Published: March 1, 2024
Chronic
and
aberrant
nucleic
acid
sensing
causes
type
I
IFN–driven
autoimmune
diseases,
designated
interferonopathies.
We
found
a
significant
reduction
of
regulatory
T
cells
(T
regs
)
in
patients
with
interferonopathies
caused
by
mutations
ADAR1
or
IFIH1
(encoding
MDA5).
analyzed
the
underlying
mechanisms
using
murine
models
that
reg
-specific
deletion
Adar1
peripheral
loss
scurfy
-like
lethal
disorders.
Similarly,
knock-in
mice
expression
an
MDA5
gain-of-function
mutant
apoptosis
severe
autoimmunity.
Moreover,
impact
deficiency
on
is
multifaceted,
involving
both
PKR
sensing.
Together,
our
results
highlight
dysregulation
homeostasis
intrinsic
RNA
as
potential
determinant
for
Abstract
ADAR
deaminases
catalyze
adenosine‐to‐inosine
(A‐to‐I)
editing
on
double‐stranded
RNA
(dsRNA)
substrates
that
regulate
an
umbrella
of
biological
processes.
One
the
two
catalytically
active
enzymes,
ADAR1,
plays
a
major
role
in
innate
immune
responses
by
suppression
sensing
pathways
which
are
orchestrated
through
ADAR1‐dsRNA‐MDA5
axis.
Unedited
immunogenic
dsRNA
potent
ligands
for
cellular
sensor
MDA5.
Upon
activation,
MDA5
leads
to
induction
interferons
and
expression
hundreds
interferon‐stimulated
genes
with
antiviral
activity.
In
this
way,
ADAR1
acts
as
gatekeeper
pathway
striking
fine
balance
between
prevention
autoimmunity.
Reduced
is
strongly
linked
development
common
autoimmune
inflammatory
diseases.
viral
infections,
exhibits
both
proviral
effects.
This
modulated
editing‐dependent
editing‐independent
functions,
such
PKR
antagonism.
Several
A‐to‐I
events
have
been
identified
viruses,
including
insidious
pathogen,
SARS‐CoV‐2
regulates
fitness
infectivity,
could
play
shaping
evolution.
Furthermore,
attractive
target
immuno‐oncology
therapy.
Overexpression
increased
observed
several
human
cancers.
Silencing
especially
cancers
refractory
checkpoint
inhibitors,
promising
therapeutic
strategy
cancer
immunotherapy
conjunction
epigenetic
The
mechanistic
understanding
holds
great
potential
applications.
article
categorized
under:
Processing
>
Editing
Modification
Disease
Development
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(2)
Published: Jan. 29, 2024
Abstract
Protein
kinase
R
(PKR)
is
a
double‐stranded
RNA
(dsRNA)
binding
protein
that
plays
crucial
role
in
innate
immunity
during
viral
infection
and
can
restrict
both
DNA
viruses.
The
potency
of
its
antiviral
function
further
reflected
by
the
large
number
viral‐encoded
PKR
antagonists.
However,
much
about
regulation
dsRNA
accumulation
activation
remains
unknown.
Since
viruses
do
not
have
an
genome
or
replication
intermediates
like
do,
PKR‐mediated
detection
context
virus
particularly
intriguing.
Here,
we
review
current
state
knowledge
regarding
antagonism
with
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 21, 2024
Abstract
Adenosine-to-inosine
editing
is
catalyzed
by
adenosine
deaminases
acting
on
RNA
(ADARs)
in
double-stranded
(dsRNA)
regions.
Although
three
ADARs
exist
mammals,
ADAR1
responsible
for
the
vast
majority
of
events
and
acts
thousands
sites
human
transcriptome.
has
been
proposed
to
form
a
stable
homodimer
dimerization
suggested
be
important
activity.
In
absence
structural
basis
ADAR1,
without
way
prevent
dimer
formation,
effect
enzyme
activity
or
site
specificity
remained
elusive.
Here,
we
report
analysis
third
RNA-binding
domain
(dsRBD3),
which
reveals
formation
through
large
inter-domain
interface.
Exploiting
these
insights,
engineered
an
interface-mutant
disrupting
ADAR1-dsRBD3
dimerization.
Notably,
disruption
did
not
abrogate
but
intricately
affected
efficiency
at
selected
sites.
This
suggests
complex
role
selection
ADARs,
makes
potential
target
modulating
RNA,
Journal Year:
2025,
Volume and Issue:
unknown, P. rna.080304.124 - rna.080304.124
Published: Jan. 8, 2025
Immune-mediated
diseases
are
common
in
humans.
The
immune
system
is
a
complex
host
defense
that
evolved
to
protect
us
from
pathogens,
but
also
plays
an
important
role
homeostatic
processes,
removing
dead
or
senescent
cells,
and
participating
tumor
surveillance.
human
has
two
arms:
the
older
innate
system,
newer
adaptive
system.
Sensing
of
foreign
RNA
critical
system’s
ability
recognize
especially
viral
infections.
However,
sensors
strongly
implicated
autoimmune
autoinflammatory
diseases,
highlighting
importance
balancing
pathogen
recognition
with
tolerance
RNAs
can
resemble
their
counterparts.
We
describe
how
bind
ligands,
this
binding
coupled
upregulation
Type
I
interferon-stimulated
genes,
ways
which
mutations
genes
play
roles
homeostasis
have
been
linked
diseases.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
Summary
ADAR1
is
a
pivotal
regulator
in
RNA-induced
immune
responses
by
catalyzing
the
conversion
of
adenosine
to
inosine
on
double-stranded
RNA.
Mutations
are
associated
with
human
autoimmune
disease,
and
targeting
has
been
proposed
for
cancer
immunotherapy.
However,
molecular
mechanisms
governing
ADAR1-mediated
RNA
editing
remain
enigmatic.
Here,
we
provide
detailed
biochemical
structural
characterizations
ADAR1.
Our
profiling
reveals
that
both
sequence
duplex
length-dependent,
but
can
well
tolerate
mismatches
near
site.
Moreover,
our
high-resolution
structures
ADAR1-RNA
complexes,
coupled
mutagenesis
studies,
revealed
basis
binding,
substrate
selection,
dimerization,
crucial
role
RNA-binding
domain
3
editing.
The
also
help
explain
potential
defects
disease-associated
mutations,
where
RNA-sequencing
analysis
further
indicate
some
mutations
preferentially
impact
RNAs
short
duplex.
findings
illustrate
mechanism
clues
deciphering
its
regulation
drug
targeting.
HIGHLIGHTS
Biochemical
preference
Atomic
resolution
two
physiological
substrates
Disease-related
dsRNA.
essential
capture